LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 20 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,369,249 | -19.6% | 785,836 | +6.1% | 0.00% | – |
| Q2 2023 | $5,436,025 | +4571.0% | 740,603 | +2451.9% | 0.00% | – |
| Q1 2023 | $116,378 | +82.9% | 29,022 | +48.7% | 0.00% | – |
| Q4 2022 | $63,635 | -9.1% | 19,520 | +3.3% | 0.00% | – |
| Q3 2022 | $70,000 | +4.5% | 18,897 | -13.0% | 0.00% | – |
| Q2 2022 | $67,000 | -59.1% | 21,731 | -29.1% | 0.00% | – |
| Q1 2022 | $164,000 | +84.3% | 30,669 | +69.5% | 0.00% | – |
| Q4 2021 | $89,000 | -42.9% | 18,093 | +2.7% | 0.00% | – |
| Q3 2021 | $156,000 | -4.9% | 17,623 | -2.1% | 0.00% | – |
| Q2 2021 | $164,000 | – | 17,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |